Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Registration Form 2008

Aug 26, 2008

29777_rf_2008-08-26_569d8fad-b8e4-4515-be7d-5b6a8cd52427.zip

Registration Form

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

S-8 1 a08-17292_3s8.htm S-8

*As filed with the Securities and Exchange Commission on August 26, 2008.*

*Registration No. 333-*

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM S-8*

*REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933*

*Abbott Laboratories*

(Exact name of registrant as specified in its charter)

Illinois 36-0698440
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
Abbott Laboratories
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of Principal Executive Offices) (Zip Code)

*ABBOTT LABORATORIES DEFERRED COMPENSATION PLAN*

(Full title of the plan)

*Laura J. Schumacher*

*Abbott Laboratories*

*100 Abbott Park Road*

*Abbott Park, Illinois 60064-6400*

(Name and address of agent for service)

Telephone number, including area code, of agent for service: (847) 937-6100

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

| Large accelerated filer | x | Accelerated
filer | o |
| --- | --- | --- | --- |
| Non-accelerated filer | o | Smaller
reporting company | o |
| (Do not check if a smaller reporting company) | | | |

*CALCULATION OF REGISTRATION FEE*

Title of securities to be registered Amount to be registered Proposed maximum offering price per share (a) Proposed maximum aggregate offering price (a) Amount of registration fee (a)
Deferred Obligations $ 60,000,000 N/A $ 60,000,000 $ 2,358

(a) The deferred obligations are unsecured obligations of Abbott Laboratories to pay deferred compensation in the future in accordance with the terms of the Abbott Laboratories Deferred Compensation Plan.

SEQ.=1,FOLIO='',FILE='C:\JMS\mblount\08-17292-3\task3111096\17292-3-ba.htm',USER='mblount',CD='Aug 26 14:35 2008'

Pursuant to General Instruction E, the contents of Abbott Laboratories Non-Qualified Deferred Compensation Plan Registration Statement on Form S-8 (File no. 333-74220) are incorporated herein by reference.

Part II. Information Required in the Registration Statement

Item 8. Exhibits

See Exhibit Index, which is incorporated herein by reference.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\mblount\08-17292-3\task3111096\17292-3-ba.htm',USER='mblount',CD='Aug 26 14:35 2008'

SIGNATURES

THE REGISTRANT. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on August 25, 2008.

ABBOTT LABORATORIES
By: /s/ Miles D. White
Miles D.
White,
Chairman of
the Board and
Chief
Executive Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\mblount\08-17292-3\task3111096\17292-3-ba.htm',USER='mblount',CD='Aug 26 14:35 2008'

Each person whose signature appears below constitutes and appoints Miles D. White and Laura Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date
/s/
Miles D. White Chairman
of the Board, August
25, 2008
Miles
D. White Chief
Executive Officer, and
Director
/s/
Thomas C. Freyman Executive
Vice President, Finance and August
25, 2008
Thomas
C. Freyman Chief
Financial Officer (Principal
Financial
Officer)
/s/
Greg W. Linder Vice
President and Controller August
25, 2008
Greg
W. Linder (Principal
Accounting Officer)
/s/
Roxanne S. Austin Director August
25, 2008
Roxanne
S. Austin
/s/
William M. Daley Director August
25, 2008
William
M. Daley
/s/
W. James Farrell Director August
25, 2008
W.
James Farrell
/s/
H. Laurance Fuller Director August
25, 2008
H.
Laurance Fuller
/s/
William A. Osborn Director August
25, 2008
William
A. Osborn

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\mblount\08-17292-3\task3111096\17292-3-ba.htm',USER='mblount',CD='Aug 26 14:35 2008'

| /s/
David A. L. Owen | Director | August
25, 2008 |
| --- | --- | --- |
| David
A. L. Owen | | |
| /s/
Boone Powell Jr. | Director | August
25, 2008 |
| Boone
Powell Jr. | | |
| /s/
W. Ann Reynolds | Director | August
25, 2008 |
| W.
Ann Reynolds | | |
| /s/
Roy S. Roberts | Director | August
25, 2008 |
| Roy
S. Roberts | | |
| /s/
Samuel C. Scott III | Director | August
25, 2008 |
| Samuel
C. Scott III | | |
| /s/
William D. Smithburg | Director | August
25, 2008 |
| William
D. Smithburg | | |
| /s/
Glenn F. Tilton | Director | August
25, 2008 |
| Glenn
F. Tilton | | |

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\mblount\08-17292-3\task3111096\17292-3-ba.htm',USER='mblount',CD='Aug 26 14:35 2008'

EXHIBIT INDEX

Exhibit No. Description
5 Opinion of Mayer Brown LLP.
23.1 Consent of Mayer Brown LLP is included in the opinion filed as
Exhibit 5 hereto.
23.2 Consent of Deloitte & Touche LLP.
23.3 Consent of Deloitte & Touche LLP.
24 Power of Attorney is included on the signature page.

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\mblount\08-17292-3\task3111096\17292-3-ba.htm',USER='mblount',CD='Aug 26 14:35 2008'